Overview

Efficacy and Safety of Treatment With Simdax® Versus Dobutrex® in Decompensated Heart Failure Patients.

Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effects of levosimendan with dobutamine on heart function in patients suffering of severe chronic heart failure.
Phase:
Phase 4
Details
Lead Sponsor:
Orion Corporation, Orion Pharma
Treatments:
Dobutamine
Simendan